cells are widely distributed, which can be stored in 
advance, and also highly proliferative and 
multipotential, so they can be one of the best seed 
cells to replace autologous hematoma cells 
transplantation for the treatment of fracture healing
 
[6]
. In recent years, the proliferation of in vitro cell 
culture is increasingly mature, which makes it 
possible to proliferate a large number of primary 
cells in the short term and can be reserved for a long 
time. In theory, it is considered that the fracture 
hematoma cell is a relatively primitive cell with 
weak antigenicity. Therefore, allograft 
transplantation may cause mild or even no immune 
rejection. But up to now, no specific experimental 
study at home and abroad was reported. 
Schuurman et al. [7] divided xenograft rejection 
in the early stage into three categories: hyperacute 
rejection (HAR), acute humoral xenograft rejection 
(AHXR), and acute cellular xenograft rejection 
(ACXR). Studies have shown that the graft non-
function were mainly due to the hyperacute rejection 
and the acute dissimilar rejection of the body fluid. 
Hyperacute rejection is a leading cause which occurs 
within 24 hours after transplantation, It is mainly the 
antibody mediated mechanism, which is the humoral 
immune response caused by the natural antibody 
IgM, and the natural antibody IgG also plays a 
certain role[8-10]. Dehoux [11] suggests that anti 
IgM and IgG play an important role in activating 
endothelial cells and complement. Especially the 
induction of anti -Gal IgG is significantly elevated in 
AHXR, which may play a major role. The diagnostic 
criteria for antibody - mediated acute graft rejection 
include 3 basic characteristics [12]: (1) 
morphological evidence for acute tissue injury. (2) 
immunological evidence of antibody action. (3) 
Serological evidence of circulating donor specific 
human leukocyte antigen (HLA) antibody or other 
donor epithelial cells antigen specific antibodies. 
One of the characteristics of AHXR is the 
infiltration of all kinds of cells to the grafts. The 
existence of neutrophils has a certain predictability 
in the diagnosis of AR, and it may represent early 
immune response is activated [13-15]. 
Fischbeck[16] study shows that DXR is mediated by 
immune cells such as mononuclear cells. 
Mononuclear phagocyte system responsible for 
recognition and rejection of xenogeneic antigen in 
xenotransplantation [17]; The lymphoid follicles in 
the spleen increases when the antigen and blood 
circulation enters the spleen and causes humoral 
immune response [18]. The results showed that after 
the ordinary rabbits hematoma cells were 
transplanted into New Zealand rabbits fracture of 1 
days、 4 days and 8 days after transplantation, a 
large number of xenohematomas survived in the 
transplanted region, no obvious degeneration and 
necrosis were found and no obvious IgM and IgG 
deposition was found around the broken end of the 
fracture. There was no significant difference in the 
infiltration of neutrophils and CD68 positive 
macrophages in the fracture area between each 
group in different time. At the same time, there was 
no significant difference in the number of splenic 
lymphoid follicles in and between groups at different 
time, and no significant proliferation of the splenic 
lymphoid follicles was found. All these indicate that 
there is no obvious rejection reaction between 
transplanted rabbit xenogeneic hematoma cells and 
their receptors in early stage, and good 
histocompatibility also imply that allogeneic 
hematoma cells transplantation is feasible, which 
provides an experimental basis for future treatment 
of fractures or bone defects. 
REFERENCES 
1.  Mizuno K,Mineo K,Tachibana T,et al.The 
osteogenetic potential of fracture 
haematoma.Subperiosteal and intramuscular 
transplantation of the haematoma[J].J Bone Joint 
Surg(Br) 1990,72(5):822-9. 
2.  Guo Hongwang,Li Yuxue. Reutilization of 
hematoma at fracture site [J]. China Journal of 
Orthopaedics and Tyaumatology,2001,14(1):50-51. 
3.  Guo Q, Liu Z, Zhanqing L I. Technical explore on 
mesenchymal stem cells in bone marrow using BrdU 
labelling[J]. Journal of North China Coal Medical 
College, 2004,6(1):4-7. 
4.  Guo Qicang,Zhang Yu,Wang Yufang. 
Characteristics and feasibility of bone marrow-
derived mesenchymal stem cells labeled with 5-
bromodexyuridine[J].Chinese Journal of Clinical 
Rehabilitation,2006,10(5):144-146. 
5.  Li Guitao, Li Huaren, Xu Hongzhang. Experiment 
Study of the Osteogenetic Potential of Bone 
Hematoma[J].Chinese Journal of Bone and Joint 
Injury , 2004,19(5):323-324. 
6.  Grundnes O, Reikers O. The importance of the 
hematoma for fracture healing in rats[J]. Acta 
Orthopaedica Scandinavica, 1993, 64(3):340-2. 
7.  SchuurmanHJ,PinoCG,PhllipsMJ,et al.Incidence of 
hyperacute rejection In pig-to primate 
transplantation using organs from hDAF-transgenic 
donors.Transplantation,2002,73(6),1146-1157 
8.  Koren E, Neethling F A, Richards S, et al. Binding 
and specificity of major immunoglobulin classes of 
preformed human anti-pig heart antibodies[J]. 
Transplant International, 1993, 6(6):351.